| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |